Indeed, the osteogenesis inhibition favours bone invasion by neuroblastoma cells [18] and here we show that the downregulation of CHD9 is correlated with metastasization and low survival rates (Figure 3A and 3D and Supplementary Figure 5A and 5D). The gene discussed is CHD9; the disease is neuroblastoma.